Advanced Medical Solutions signs German deal for surgical adhesive:
This article was originally published in Clinica
Executive Summary
Advanced Medical Solutions, the AIM-listed, Winsford, UK-based woundcare firm, has signed a distribution deal with a German firm for its LiquiBand adhesive wound closure products. Resorba Clinicare, based in Nuremberg, will distribute the range in Germany, focusing on the surgical wound closure market. An alternative to stitching and stapling, LiquiBand is already used in UK A&E departments, and LiquiBand Surgical was recently launched for the operating theatre. AMS says the UK's NHS spends about $100m annually on advanced woundcare dressings. Meanwhile, it is estimated that 40% of the world's $3bn suture and staple market could move to medical glues in the future.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.